PLA2G4F and nonpapillary renal cell carcinoma: VEGFA, COL1A1, COL3A1, EGF, HK2, SHMT2, PLA2G4F, ADH1A, ADH1C, CAV1, TIMP1 and PIPOX were selected as drugs targets of BSJPF in ccRCC patients.